Daiichi Sankyo and Kitasato Institute forming a joint venture called Kitasato Daiichi Sankyo Vaccine Co. Ltd. to develop, manufacture, and market vaccines and biologics for humans and animals

Daiichi Sankyo Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Kitasato Institute

Japan / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced